SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075
http://www.w3.org/2000/01/rdf-schema#comment
"CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy."
xsd:string
http://purl.uniprot.org/uniprot/#_39FDDB0E9A94C4A01A363DF2372FC2F86EB2633EF22C7D9D6F75A93213063B98045E7087368B89743929284AEC689748
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075
http://purl.uniprot.org/uniprot/Q8NI51
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075
http://purl.uniprot.org/uniprot/#_Q8NI51-mappedCitation-35132075
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F58B9965D8419CA32EEF61FE0930122FFF285509AC3C0469B8E8E3271DFD3681F0DA05231714E11C9634B4C93ACA5075